An Echelon Media Company
Tuesday October 20th, 2026

Does Covid vaccines deprive visa and reduce fertility? – fact-checked

ECONOMYNEXT – Sajith* has vowed to wait until any vaccine other than China-made Sinopharm vaccine is made available.

The 28-year old youth from a Colombo suburb area is waiting to leave Sri Lanka once all the Covid-19 restrictions are over.

“Sinopharm could deny me a visa from the UK. I am also concerned over possible fertility issues with regard to vaccines,” he told EconomyNext, asking not to reveal his real identity given he has yet to be vaccinated.

“Many of my friends have decided not to get the vaccines, because there are some stories that these vaccines reduce fertility. But I want to get the vaccines because they are important for me to go abroad. Otherwise I too prefer to join my friends”

Sajith is one of those thousands of Sri Lankan youth who have been taking a risk without any vaccines so far despite top health officials have advised Sri Lankans to get any vaccine available at the moment.

However, there has been claims of visa denial and fertility reduction have hindered the latest vaccination programme among the people aged 20-29 years.

Sri Lanka started vaccinating this group from September 06 with the above 30 years of age groups being almost completely vaccinated by the government’s vaccination drive.

As of October 29, health authorities have said they had vaccinated nearly 60 percent out of a total 3.3 million in the 20-29 age group with the first dose and nearly 19 percent with both doses.

The vaccination is done mainly using the Chinese manufactured Sinopharm vaccine, the most used vaccine in the country along with AstraZeneca, Moderna, Pfizer, and Sputnik V.

False and misleading claims about Covid-19 vaccines, fertility and visa denial are still circulating online, despite not being supported by evidence.

The claims on some countries requesting travelers, students and employees coming from abroad to be vaccinated with a specific vaccine which has been recognized by the country has weighed on Sri Lanka’s vaccination programme.

People say they have got social media messages saying that travelers who had not been immunized with a particular recognized vaccine are being sent for mandatory quarantine or denied entry to the country.

“Along with other information circulating in the social media, the information saying countries won’t accept Sinopharm as a valid vaccine for the travelers to enter the country is a major issue” a student of the Sri Jayewardenepura University told EconomyNext.

“Most of the students in the university expects to travel abroad for higher education after the completion of the course in university”

“With that more students are demanding Pfizer of Moderna vaccines”

Fact checking on visa entry for those fully vaccinated with Sinopharm

According to a foreign ministry document on the entry requirement by various countries seen by EconomyNext, much of the information about not being able to get a visa after taking a certain Covid 19 vaccine is wrong.

An official who is dealing with inquiries over vaccine requirements for visas said people do not accept what they say.

“When we say you can take Sinopharm, these people who are not informed say they can’t take it because their desired country doesn’t accept it,” the official told EconomyNext on condition of anonymity because he is not allowed to officially talk to the media.

The foreign ministry document shows some countries do not require vaccines and other countries requesting mandatory vaccination do not reject Sinopharm.

However, Sri Lanka is currently included in the list of high risk countries by Bulgaria, Bahrain, Qatar, Denmark, Finland, Germany, Malta, Turkey, Slovakia, and Thailand due to delta covid-19 variant.

The officials said when Sri Lanka is in the list of high risk countries, even if the people have been vaccinated with Prizer or Moderna, still they will not be allowed to enter the desired country because of Sri Lanka being in the red list.

“But in countries like Australia if you have been vaccinated with a vaccine that has not been approved by their authorities, you will need to undergo a quarantine time period, can be 10,14 or 21 days and should be tested negative in a PCR test before being released,” the official said.

“That is the requirement of those countries if you have taken a different vaccine.”

“if you are a person with some medical condition that has been advised to take a specific vaccination. In those cases, they have to make a special request to the Director General of Health, and he will give the approval after going case by case to get that specific vaccine.”

He said for ordinary travelers, there is no issue with regard to vaccines.

“Many countries now recognize the vaccines and if you have been jabbed with a vaccine that has not been recognized there, then you will have to undergo the quarantine period. But there are no restrictions saying you can’t enter a country.”

He said some Sri Lankans are demanding specific vaccines to save the money they have to pay in the quarantine process.

“Even when you go to China after being jabbed with the Sinopharm vaccine, you will have to go under a quarantine period for 21 days.”

Saudi Arabia requests the travelers to take a booster dose in the event of people having only got two Sinopharm.

“But they (Saudi) have allowed them to take a booster dose before coming or they have given the facility to take the booster dose after coming to Saudi Arabia,” he said.

“But our people want to take it before going there, thinking they won’t be accepted or there will be issues.

“In Europe, Germany and France were the only countries that did not accept the Sinopharm vaccine. But we are checking to see whether they have changed the rules. Because from time to time they change the rules.”

“But other European countries, like the UK, Italy and others, do not have such restrictions.”

Fact checking on Covid vaccines reducing fertility 

Health authorities said currently there is no evidence to prove any theory circulating in these platforms.

The Centre for Diseases Control and Prevention (CDC) in the USA has said there is currently no evidence that antibodies made following COVID-19 vaccine or its ingredients would cause any problems with becoming pregnant now or in the future.

CDC said, many people have become pregnant after receiving a COVID-19 vaccine, including some who got vaccinated during COVID-19 vaccine clinical trials.

In addition, a recent report using the data showed that 4,800 people had a positive pregnancy test after receiving a first dose of an mRNA COVID-19 vaccine.

 Another report using data from 8 U.S. healthcare systems documented more than 1,000 people who completed COVID-19 vaccination (with any COVID-19 vaccine) before becoming pregnant.

CDC has further said currently no evidence shows that any vaccines, including COVID-19 vaccines, cause male fertility problems.

Another study shows that the vaccines would not remain in ovaries as spreaded by social media.

The study involved giving rats a much higher dose of vaccine than that given to humans (1,333 times higher).

Only 0.1% of the total dose ended up in the animals’ ovaries, 48 hours after injection.

Far more – 53% after one hour and 25% after 48 hours – was found at the injection site (in humans, usually the arm). The next most common place was the liver (16% after 48 hours), which helps get rid of waste products from the blood.

Source: https://healthfeedback.org/claimreview/covid-19-vaccines-dont-affect-ovaries-or-fertility-in-general-the-vaccines-are-highly-effective-at-preventing-illness-and-death/

The vaccine is delivered using a bubble of fat containing the virus’s genetic material, which kick-starts the body’s immune system.

And those promoting this claim cherry-picked a figure which actually referred to the concentration of fat found in the ovaries.

Fat levels in the ovaries did increase in the 48 hours after the jab, as the vaccine contents moved from the injection site around the body.

But, crucially, there was no evidence it still contained the virus’s genetic material.

We don’t know what happened after 48 hours as that was the limit of the study.

A recent small study of 45 healthy men who received an mRNA COVID-19 vaccine looked at sperm characteristics, like quantity and movement, before and after vaccination.

Researchers found no significant changes in these sperm characteristics after vaccination.

Fever from illness has been associated with short-term decrease in sperm production in healthy men, it said.

“Although fever can be a side effect of COVID-19 vaccination, there is no current evidence that fever after COVID-vaccination affects sperm production,” the CDC said.

Also another recent study done in South Florida, USA has shown that while COVID-19 may harm the lungs, it’s a systemic disease that can also affect the heart, kidneys, brain and other organs, and those effects can last long after someone has recovered.

Among the list of ailments, mounting evidence suggests that COVID-19 may sabotage men’s sexual health.

The research was done by collecting the penile tissue from patients undergoing surgery for penile prosthesis surgery due to severe Erectile Dysfunction under an Institutional Review Board of the University of Miami Miller School of Medicine approved protocol.

Patients’ ages ranged from 65 to 71 years old, and all were of Hispanic ethnicity.

Two specimens were obtained from males with a history of COVID-19 infection and two specimens were obtained from men with no history of infection.

The results of the research have revealed that widespread endothelial cell dysfunction from COVID-19 infection can contribute to resultant erectile dysfunction. Future studies will evaluate novel molecular mechanisms of how COVID-19 infection can lead to Erectile Dysfunction.

This shows vaccination does not affect fertility, but the effect of Covid-19 infection does.

Sri Lanka’s Sampath Bank, David Pieris Automobiles launch vehicle financing partnership

ECONOMYNEXT – Sri Lanka’s Sampath Bank and David Pieris Automobiles are partnering to offer customers preferential vehicle financing and ownership benefits.

Under the collaboration, customers purchasing vehicles through David Pieris Automobiles will receive a 0.5 percentage point reduction on published vehicle lease interest rates, subject to terms and conditions.

They will also have access to vehicle insurance premium loans with no interest if settled within two months, along with Sampath Bank credit cards that carry no joining fee and offer 0% interest instalment plans for insurance payments for up to 12 months.

David Pieris Automobiles, the four-wheeler sales arm of the David Pieris Group and distributor of GWM brands including HAVAL, TANK and ORA, as well as BAIC models, will provide additional customer benefits including free vehicle registration and a third labour-free vehicle service.

The two companies said the partnership reflects a shared commitment to meeting evolving mobility needs through accessible financing and automotive solutions. (Colombo/Oct20/2026)

Continue Reading

Sri Lanka’s Access Engineering drops S Asia logistics hub project, expects Rs1.45bn recovery

ECONOMYNEXT — Sri Lanka’s Access Engineering PLC said shareholders have agreed not to proceed with the South Asia Commercial and Logistics Hub project, following an initial corporate disclosure made in April 2023.

The parties have agreed to enter into a settlement agreement for the orderly termination of the project and all related agreements.

Under the planned settlement arrangements, Access Engineering anticipates recovering approximately 1.453 billion rupees from its total investment of roughly 1.762 billion rupees.

“The decision was made in view of changes in external circumstances, including adjustments to the project’s implementation environment and timetable, together with the respective commercial considerations of the parties,” Managing Director Rohana Fernando said in a filing to the Colombo Stock Exchange.

Access Engineering holds a 15 percent shareholding in South Asia Commercial and Logistics Hub Limited.

Under the settlement terms, the company expects to receive 3.286 million US dollars (equivalent to approximately 1.087 billion rupees) as its proportionate share of the settlement refund.

It will also receive approximately 365 million rupees representing its share of available distributable funds, based on an indicative exchange rate of 331 rupees per US dollar.

In its audited consolidated financial statements for the year ended March 31, 2026, the group had already recognized its share of losses amounting to approximately 387 million rupees, leaving the carrying value of the investment at roughly 1.38 billion rupees.

“Based on the anticipated settlement proceeds and the carrying value of the investment, no further material financial loss is presently anticipated in the Group’s consolidated financial statements,” Fernando said.

However, because the investment is carried at cost in the company’s separate financial statements, Access Engineering expects to recognize a company-level loss of approximately 310 million rupees.

The company noted that the final figures remain subject to the exchange rates applicable on actual transaction or payment dates, final settlement arrangements, and applicable accounting adjustments. (Colombo/Oct20/2026)

Continue Reading

Sri Lanka rupee weaker at 331.75/90 to US dollar spot, bond yields higher

ECONOMYNEXT – Sri Lanka’s rupee was quoted at 331.75/90 to the US dollar in the spot market on Tuesday, weaker from 331.60/70 the previous day, while bond yields were quoted higher, dealers said.

A bond maturing on 15.09.2029 was quoted at 11.10/30 percent, up from 11.10/25 percent.

A bond maturing on 01.08.2030 was quoted at 11.65/70 percent, up from 11.50/60 percent.

A bond maturing on 01.12.2031 was quoted at 11.90/12.00 percent.

A bond maturing on 15.01.2033 was quoted at 12.25/35 percent, up from 12.25/30 percent.

A bond maturing on 15.06.2034 was quoted at 12.50/55 percent, up from 12.40/50 percent.

The telegraphic transfer rate for the dollar was 327.10 buying, 336.10 selling; the euro was 364.3987 buying, 378.1795 selling; pound was 434.5676 buying, 448.6760 selling.

On the Colombo Stock Exchange the All Share Price Index was down 0.09 percent, or 18.32 points, at 20,041; while the S&P SL20 was broadly unchanged at 5,701. (Colombo/Oct20/2026)

Continue Reading

Global financial markets face rising risks from AI, bond yields, and cyberattacks: IMF

Financial markets have remained resilient amid solid economic growth and strong corporate earnings, while financial conditions have been relatively accommodative. However, there is no room for complacency.

Three key risks have been increasing, each with the potential for broader implications: an artificial intelligence-driven market correction, a sharper rise in sovereign bond yields, and cyberattacks.

Vulnerabilities beneath the surface could determine how damaging the manifestation of these risks would be, as we detail in the latest Global Financial Stability Report. An AI market correction could trigger broad deleveraging across asset classes. A bond yield shock could reprice assets and reduce the collateral value of bonds in financial transactions. A cyberattack could disrupt critical operations and weaken confidence. High borrowing, scarce liquidity, and tighter links across markets could amplify the impact into broader financial stress.

Heavy reliance on AI

AI has become an important support for the global economy and financial markets, as discussed in the World Economic Outlook. Investment in data centers, semiconductors, and related infrastructure has spurred economic activity, while companies driving the AI boom have delivered exceptional earnings growth. But faltering AI investment and profitability could challenge optimistic expectations and trigger a correction in asset prices linked to the AI industry.

Growing leverage could be a catalyst for such a correction. Hyperscalers, as the largest data center operators are known, are borrowing more and more, while investors have been leveraging to invest in AI stocks. Circular financing arrangements in the AI sector, involving equity and debt flows between AI firms, suggest that stress at key companies receiving investment could lower revenue forecasts and investment valuations, which in turn would weaken the value of the accumulated debt in those deals. Our review of 14 such transactions since 2023 found about $300 billion in equity investments and $650 billion in debt, in exchange for $1.4 trillion in future revenue commitments.

Government debt risks

Sovereign bond yields have risen amid renewed inflation pressures from higher energy prices, fiscal concerns, and, in some cases, stronger-than-expected economic growth. It may be the case that bond yields are moving back toward the levels seen before the global financial crisis, when growth and inflation were higher than in the 2010s. At the same time, risks of adverse feedback loops related to higher fiscal imbalances and leveraged trades in bond markets are increasing. In addition, as central banks have been reducing their balance sheets, greater reliance on price-sensitive investors could contribute to further yield volatility.

As government bonds underpin the global financial system, the consequences of higher sovereign yields could extend well beyond public debt. Higher yields could further raise discount rates and depress valuations across other assets, including those that are AI-related, while reducing the value of bonds used as collateral.

Cyberattacks

As finance becomes more digital and interconnected, cyber disruptions have emerged as a growing source of systemic risk. A major incident could disrupt payments, trading, access to deposits, or other critical financial services. The danger is particularly acute if an attack affects a major financial institution, payment system, cloud provider, or software platform, allowing disruption to spread through an increasingly interconnected financial system.

Importantly, cyber threats can be hard to contain. In more than 70 percent of reported cases so far this year, software providers had almost no time to patch vulnerabilities before attackers exploited them. That’s more than double the share in 2021, when providers typically had close to 300 days to fix vulnerabilities. Frontier AI models could accelerate both attacks and defenses, increasing the importance of cyber resilience, incident reporting, crisis preparedness, and oversight of critical third-party providers.

Financial fault lines

Underlying vulnerabilities could amplify the impact of these three risks into systemic events.

Although global banks, the core of the financial system, remain resilient overall under our adverse stress scenario, there could be weak links. Banks with 22 percent of global banking assets would emerge with post-stress capital ratios below regulatory limits, an increase from 18 percent a year ago. Moreover, the links of such banks with nonbank financial intermediaries are deepening, creating additional channels for transmitting stress.

Beyond banking, pension funds and insurers have steadily increased allocations to illiquid assets and derivatives, while relying more heavily on the same asset managers. This increases the risk that at a time of stress, they could face sudden liquidity needs through margin calls and could react in similar ways—for example by selling the same assets—amplifying market moves. Some of these institutions also hold illiquid private credit, another potential amplification channel.

At the same time, as borrowers have become more leveraged, some direct-lending funds have committed to provide funding on demand. If financial conditions tighten, borrowers could draw on those facilities just as the funds that provide them could be facing their own liquidity pressures. Such dynamics could further reduce credit to companies that need it most, with consequences for the broader economy.

In emerging and developing economies, bond yields have also risen, although their spreads compared with their advanced economy peers remain fairly compressed. However, recent global shocks have diminished buffers, thereby increasing external vulnerabilities and reducing their ability to absorb stress.

Policies to safeguard

With government debt high, inflation pressures re-emerging, and higher borrowing costs, policymakers have much less room to support the economy following shocks than in the past.

We see three priorities for action:

-Debt needs to be put on a sustainable path.
– Leverage and liquidity mismatches in AI, private credit, and other nonbank financial sectors should be limited, including through sectoral capital and concentration requirements on banks’ exposures to these sectors.
– Cyber defense capabilities need to be strengthened, for example through better incident reporting and resilience testing among financial institutions.
Emerging and developing economies should also rebuild buffers while financial conditions remain accommodative. Proactive policies are the best way to prepare as risks are rising.

Continue Reading

Sri Lanka rupee closes weaker at 331.60/70 to US dollar spot, bond yields higher

ECONOMYNEXT – Sri Lanka’s rupee closed at 331.60/770 to the US dollar in the spot market on Monday, weaker from 331.25/35 the previous day, while bond yields closed higher, dealers said.

A bond maturing on 15.09.2029 closed at 11.10/25 percent, up from 11.05/15 percent.

A bond maturing on 01.08.2030 closed at 11.50/60 percent, up from 11.40/50 percent.

A bond maturing on 15.10.2030 closed at 11.65/75 percent, up from 11.50/55 percent.

A bond maturing on 01.02.2031 closed at 11.75/80 percent, up from 11.55/65 percent.

A bond maturing on 15.12.2032 closed at 11.90/12.10 percent, up from 11.80/90 percent.

A bond maturing on 15.01.2033 closed at 12.25/30 percent, up from 11.95/12.05 percent.

A bond maturing on 15.06.2034 closed at 12.40/50 percent, up from 12.20/25 percent. (Colombo/Oct19/2026)

Continue Reading

Sri Lanka shares close down on Monday; ASPI falls 0.62-pct

ECONOMYNEXT – Sri Lanka’s Colombo Stock Exchange closed down on Monday, CSE data showed, with the benchmark All Share Price Index falling 0.62 percent.

The ASPI was down 125.63 points at 20,059.42, while the more liquid S&P SL20 was down 0.51 percent, or 29.36 points, at 5,709.47.

Raynal Wickremeratne, Head of Research and Strategy at NDB Securities, noted that market turnover remained low, with local sentiment reflecting the recent volatility and declines across regional Asian markets.

Positive contributors to the ASPI were Watawala Plantations (up 2.43 percent at 46.40 rupees), Richard Pieris and Company (up 1.54 percent at 26.40 rupees), Ceylon Cold Stores (up 0.62 percent at 122.00 rupees), and Commercial Bank of Ceylon (up 0.13 percent at 198.25 rupees).

Dialog Axiata (down 2.27 percent at 43.00 rupees), Overseas Realty (Ceylon) (down 2.00 percent at 49.00 rupees), John Keells Holdings (down 1.67 percent at 17.70 rupees), Hemas Holdings (down 1.29 percent at 30.50 rupees), and Hatton National Bank (down 0.79 percent at 375.00 rupees) were top negative contributors.

Market turnover was 680.32 million rupees. The banking sector led turnover with 188.71 million rupees, followed by capital goods with 177.78 million rupees.

Crossings were recorded in Seylan Bank for 98 million rupees and John Keells Holdings for 26 million rupees. (Colombo/Oct19/2026)

Continue Reading